The University of Southampton
University of Southampton Institutional Repository

An investigation into mode of action and selective toxicity of the novel antiparasitic emodepside

An investigation into mode of action and selective toxicity of the novel antiparasitic emodepside
An investigation into mode of action and selective toxicity of the novel antiparasitic emodepside
Emodepside is a novel anthelmintic with resistance breaking properties. Its mode of action has been extensively studied in the model organism Caenorhadbitis elegans. In this worm emodepside elicits an inhibition of feeding, egg-laying and locomotion, which indicate a potent disruption of normal neuromuscular transmission. Mutagenesis screening for C. elegans resistant to emodepside revealed a calcium activated potassium channel SLO-1 as a target of emodepside. SLO-1 belongs to a family of channels that are highly conserved throughout the animal phyla to regulate cell excitability. This project addressed the question of whether or not the basis for the selective toxicity of emodepside resides in its pharmacological specificity for the nematode SLO-1 dependent signalling pathway. A bioinformatics analysis was used to identify the human channel KCNMA1 as one of the closest mammalian homologues to SLO-1. Two expression systems that enabled the pharmacological characterisation, and comparison, of SLO-1 and KCNMA1 have been established. In the first system plasmids carrying C. elegans slo-1 and human KCNMA1 behind the native pslo-1 promoter, a pan-neuronal promoter, a body-wall muscle promoter or a pharyngeal muscle promoter have been successfully employed for generating transgenic C. elegans expressing either SLO-1 or KCNMA1. These transgenics were deployed to permit functional and pharmacological characterisation of the channels in vivo. Behavioural and electrophysiological assays confirmed that KCNMA1 was functionally expressed in this model organism; observations reinforced by the sensitivity of these strains to mammalian BK channel activators NS1619 and rottlerin. Importantly, with regard to selective toxicity, strains expressing SLO-1 were 100 fold more sensitive to emodepside than strains expressing functional KCNMA1. To more directly assess if emodepside interacts with these channels, SLO-1 and KCNMA1 were expressed in HEK293 cells. Whole cell currents from cells expressing SLO-1 or KCNMA1 were inhibited by a selective inhibitor of mammalian BK channels penitrem A. Activation of SLO-1 currents required micromolar Ca2+ in agreement with previously published data. The experimental conditions required to obtain SLO-1 currents constrained the time-course over which the analysis of emodepside effects could be observed. Nonetheless, these experiments demonstrate emodepside potentiation of both SLO-1 and KCNMA1 currents. Taken together with the genetic evidence this thesis supports the hypothesis that emodepside inhibits neuromuscular activity in C. elegans by facilitating activation of SLO-1. Overall the data support the notion that chemical biology targeted towards SLO-1 channel pharmacophores may provide an important route to resistant breaking anthelmintic drugs.
University of Southampton
Crisford, Anna
135675e1-a172-4d93-989b-93d1efb022c3
Crisford, Anna
135675e1-a172-4d93-989b-93d1efb022c3
Holden-Dye, Lindy
8032bf60-5db6-40cb-b71c-ddda9d212c8e
O'Connor, Vincent
8021b06c-01a0-4925-9dde-a61c8fe278ca
Walker, Robert J.
b6597591-587e-488a-8a54-89156c42ce8d

Crisford, Anna (2011) An investigation into mode of action and selective toxicity of the novel antiparasitic emodepside. University of Southampton, Centre for Biological Sciences, Doctoral Thesis, 286pp.

Record type: Thesis (Doctoral)

Abstract

Emodepside is a novel anthelmintic with resistance breaking properties. Its mode of action has been extensively studied in the model organism Caenorhadbitis elegans. In this worm emodepside elicits an inhibition of feeding, egg-laying and locomotion, which indicate a potent disruption of normal neuromuscular transmission. Mutagenesis screening for C. elegans resistant to emodepside revealed a calcium activated potassium channel SLO-1 as a target of emodepside. SLO-1 belongs to a family of channels that are highly conserved throughout the animal phyla to regulate cell excitability. This project addressed the question of whether or not the basis for the selective toxicity of emodepside resides in its pharmacological specificity for the nematode SLO-1 dependent signalling pathway. A bioinformatics analysis was used to identify the human channel KCNMA1 as one of the closest mammalian homologues to SLO-1. Two expression systems that enabled the pharmacological characterisation, and comparison, of SLO-1 and KCNMA1 have been established. In the first system plasmids carrying C. elegans slo-1 and human KCNMA1 behind the native pslo-1 promoter, a pan-neuronal promoter, a body-wall muscle promoter or a pharyngeal muscle promoter have been successfully employed for generating transgenic C. elegans expressing either SLO-1 or KCNMA1. These transgenics were deployed to permit functional and pharmacological characterisation of the channels in vivo. Behavioural and electrophysiological assays confirmed that KCNMA1 was functionally expressed in this model organism; observations reinforced by the sensitivity of these strains to mammalian BK channel activators NS1619 and rottlerin. Importantly, with regard to selective toxicity, strains expressing SLO-1 were 100 fold more sensitive to emodepside than strains expressing functional KCNMA1. To more directly assess if emodepside interacts with these channels, SLO-1 and KCNMA1 were expressed in HEK293 cells. Whole cell currents from cells expressing SLO-1 or KCNMA1 were inhibited by a selective inhibitor of mammalian BK channels penitrem A. Activation of SLO-1 currents required micromolar Ca2+ in agreement with previously published data. The experimental conditions required to obtain SLO-1 currents constrained the time-course over which the analysis of emodepside effects could be observed. Nonetheless, these experiments demonstrate emodepside potentiation of both SLO-1 and KCNMA1 currents. Taken together with the genetic evidence this thesis supports the hypothesis that emodepside inhibits neuromuscular activity in C. elegans by facilitating activation of SLO-1. Overall the data support the notion that chemical biology targeted towards SLO-1 channel pharmacophores may provide an important route to resistant breaking anthelmintic drugs.

Text
Anna_Crisford_Thesis_2011.pdf - Version of Record
Restricted to Registered users only
Download (5MB)

More information

Published date: 30 September 2011
Organisations: University of Southampton, Centre for Biological Sciences

Identifiers

Local EPrints ID: 338971
URI: http://eprints.soton.ac.uk/id/eprint/338971
PURE UUID: f3b3792f-8738-4da8-b0b1-029c190e48da
ORCID for Anna Crisford: ORCID iD orcid.org/0000-0001-5775-643X
ORCID for Lindy Holden-Dye: ORCID iD orcid.org/0000-0002-9704-1217
ORCID for Vincent O'Connor: ORCID iD orcid.org/0000-0003-3185-5709

Catalogue record

Date deposited: 29 May 2012 15:34
Last modified: 15 Mar 2024 03:31

Export record

Contributors

Author: Anna Crisford ORCID iD
Thesis advisor: Lindy Holden-Dye ORCID iD
Thesis advisor: Vincent O'Connor ORCID iD
Thesis advisor: Robert J. Walker

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×